SECURITIES AND EXCHANGE COMMISSION
Washington. D.C. 20549
SCHEDULE 13D
(Rule l3d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 7)(1)
Bio-Medical Automation, Inc.
-----------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.10 par value per share
-----------------------------------------------------------------------------
(Title of Class of Securities)
09056V105
-----------------------------------------------------------------------------
(CUSIP Number)
Steven N. Bronson
900 Third Avenue, Suite 201
New York, New York 10022 (212)
610-2778
with a copy to:
James A. Prestiano, Esq.
317 Madison Avenue, Suite 2310
New York, New York 10017
(212) 949-9696
-----------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
May 5, 2000
-----------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule l3d-l(e), 13d-1(f) or 13d-1(g), check the
following box [ ]
Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7(b)
for other parties to whom copies are to be sent.
(Continued on following pages)
--------------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be 'filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes)
<PAGE>
CUSIP No. 09056V105
-----------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Steven N. Bronson
-----------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
-----------------------------------------------------------------------------
3. SEC USE ONLY
-----------------------------------------------------------------------------
4. SOURCE OF FUNDS
Not Applicable
-----------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
-----------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
USA
-----------------------------------------------------------------------------
NUMBER OF 7. SOLE VOTING POWER
SHARES 576,647
BENEFICIALLY ---------------------------------------------------------
OWNED BY 8. SHARED VOTING POWER
EACH 0
REPORTING ---------------------------------------------------------
PERSON 9. SOLE DISPOSITIVE POWER
WITH 576,647
---------------------------------------------------------
10. SHARED DISPOSITIVE POWER
0
-----------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
576,647
-----------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [X]
-----------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (1l)
65.2%
-----------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
-----------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT
<PAGE>
CUSIP No. 09056V105 SCHEDULE 13D
Item 1. Security and Issuer.
Except as expressly restated and amended below, the Schedule 13D and
amendments thereto, as filed on behalf of Steven N. Bronson with respect to the
shares of common stock $.10 par value per share (the "Common Stock") of
Bio-Medical Automation, Inc., a Colorado corporation, with its principal offices
located at 900 Third Avenue, Suite 201, New York, New York 10022 (the "Issuer"),
remains in full force and effect.
Item 2. Identity and Background.
(a) This Amendment No. 7 to Schedule 13D is filed on behalf of Steven N.
Bronson.
(b) Mr. Bronson's business address is 900 Third Avenue, Suite 201, New
York, New York 10022.
(c) Mr. Bronson is President of Catalyst Financial LLC ("Catalyst"), a
broker-dealer registered under the Act.
(d) During the last five years Mr. Bronson has not been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors).
(e) Mr. Bronson has not, during the last five years, been a party to a
civil proceeding of a judicial or administrative body of competent jurisdiction
and as a result of such proceeding was or is subject to a judgment, decree or
final order enjoining further violations of, or prohibiting or mandating
activities subject to the federal or state securities laws or finding any
violation with respect to such laws.
(f) Mr. Bronson is a citizen of the United States of America.
Item 3. Source and Amount of Funds or Other Consideration.
On May 5, 2000 the Issuer issued to Steven N. Bronson, in lieu of an annual
salary of forty eight thousand dollars ($48,000), 64,000 shares of the
Corporation's Common Stock that number of shares being equal in value to forty
eight thousand dollars ($48,000) based on the market value of the Corporation's
Common Stock on May 4, 2000.
Item 4. Purpose of Transaction.
On May 5, 2000 the Issuer issued to Steven N. Bronson 64,000 shares of the
Corporation's Common Stock in lieu of Mr. Bronson's annual salary of forty eight
thousand dollars ($48,000).
<PAGE>
Item 5. Interest in Securities of the Issuer.
(a)(b) Mr. Bronson may be deemed to beneficially own an aggregate of
576,647 shares of the Issuer's Common Stock, representing approximately 65.2% of
the total shares of Common Stock deemed outstanding. Mr. Bronson owns of record
399,147 shares of Common Stock, as to which he possesses sole voting and
disposition power. Additionally, Mr. Bronson owns options and warrants to
purchase 177,500 shares of Common Stock at exercise prices ranging at $.75 per
share to $1.25 per share. These options and warrants are set to expire between
April 1, 2001 and February 15, 2003.
Mr. Bronson's wife, Kimberly Bronson, owns, an aggregate of 30,000 shares
of Common Stock and with respect to such shares, Mr. Bronson expressly disclaims
any beneficial ownership.
(c) Not applicable.
(d) No other person is known to have the right to receive or the power to
direct the receipt of dividends from, or the proceeds from the sale of such
securities of the Issuer.
(e) Not Applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
None
Item 7. Material to be Filed as Exhibits.
None
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: July 12, 2000
/s/ Steven N. Bronson
--------------------------
(Signature)
Steven N. Bronson
--------------------------
(Name/Title)
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (See 18 U.S.C. Section l001).
